Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02750475 · ClinicalTrials.gov registry record · NA

Human Phototoxicity Test

A NA study of Sunscreening Agents, sponsored by Bayer.

Completed
Registry status
NA
Development phase
35
Enrollment target
1
Study location

NCT02750475: Completed NA study of Sunscreening Agents, sponsored by Bayer.

NCT02750475 is a NA study of Sunscreening Agents that has completed, run by Bayer. The registered enrollment target is 35 participants, below the 79-participant average among 21 other Sunscreening Agents trials with a reported enrollment target (56% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02750475, a NA study of Sunscreening Agents, has completed, sponsored by Bayer.

COMPLETED
Registry status
NA
Development phase
35 participants
Enrollment target
1
Study location

Study Summary

To determine the phototoxic potential of a topically applied article in human subjects

Conditions Studied

Interventions

  • OTHER Untreated Skin
  • DRUG Sunscreen Sport Lotion (BAY987516)

Study Locations (1)

New Jersey

  • - Piscataway

Trial Details

FieldValue
Enrollment Target 35 participants
Start Date 2016-05-02
Est. Completion 2016-05-06
Phase NA
Bayer

591 total trials

What the finished NCT02750475 record still lists

NCT02750475 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 79-participant average among 21 other Sunscreening Agents trials with a reported enrollment target (56% lower).

The record links to 1 condition, with Sunscreening Agents appearing as the primary indexed condition, and to 2 interventions - of which Untreated Skin is the first listed.

NCT02750475 reports a single indexed study location in New Jersey.

Frequently Asked Questions

What is clinical trial NCT02750475 about?

NCT02750475 is a clinical study titled "Human Phototoxicity Test". To determine the phototoxic potential of a topically applied article in human subjects

What is the current status of trial NCT02750475?

This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2016-05-02. Estimated completion is 2016-05-06.

What conditions does trial NCT02750475 study?

This clinical trial studies the following conditions: Sunscreening Agents.

What interventions are being tested in trial NCT02750475?

The interventions under investigation include: Untreated Skin (OTHER), Sunscreen Sport Lotion (BAY987516) (DRUG).

Who is sponsoring clinical trial NCT02750475?

This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02750475 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sunscreening Agents

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02750475's enrollment target sits among peer trials

35 6th of 21 higher than 15 of 21 other Sunscreening Agents trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Sunscreening Agents trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01697371 · 35 participants · NA

    Proton Therapy in the Treatment of Liver Metastases

  • NCT01940757 · 35 participants · Phase 1

    Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae

  • NCT02235857 · 35 participants · NA

    Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children

  • NCT02637934 · 35 participants · Phase 1

    Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02750475, the US trial registry maintained by the National Library of Medicine. NCT02750475 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.